{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sugar Land",
      "state": "TX",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81644",
      "recalling_firm": "QuVa Pharma, Inc.",
      "address_1": "1075 W Park One Dr Ste 100",
      "address_2": "N/A",
      "postal_code": "77478-2576",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "CA only",
      "recall_number": "D-0295-2019",
      "product_description": "Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma 1075 West Park One Drive Suite 100 Sugar Land, TX 77478. Product Code 70092-9035-05",
      "product_quantity": "168 bags",
      "reason_for_recall": "Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride",
      "recall_initiation_date": "20181121",
      "center_classification_date": "20181212",
      "termination_date": "20190501",
      "report_date": "20181219",
      "code_info": "Lot #:10016014 Exp. 01/06/2019"
    }
  ]
}